טוען...
Elderly acute myeloid leukemia: Assessing risk
Treatment of older adults with acute myeloid leukemia (AML) is challenging in part due to the difficulty of accurately predicting risks and benefits of available therapies. While older patients represent the majority of those with newly diagnosed disease, there remains no consensus regarding optimal...
שמור ב:
| הוצא לאור ב: | Curr Hematol Malig Rep |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4466909/ https://ncbi.nlm.nih.gov/pubmed/25939828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-015-0257-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|